![](http://www.thielerlaw.com/assets/news/P1TRHtMD_Hansen_Medical_Logo.jpeg)
Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Hansen Medical Inc (NASDAQ: HNSN) acted responsibly on behalf of investors’ profitability in the planned $80 million sale to Auris Surgical Robotics Inc.
On April 20, 2016, Hansen Medical Inc (NASDAQ: HNSN) and Auris Surgical Robotics Inc announced that they had entered into a merger agreement. Under the terms of the merger agreement, Auris Surgical Robotics will offer Hansen Medical shareholders $4.00 per share in cash for all outstanding shares.
Based in Mountain View, CA, and founded in 2002 Hansen Medical Inc develops, manufactures, and sells medical robotics designed for the positioning, manipulation, and control of catheters and catheter-based technologies.
The investigation focuses on whether NASDAQ: HNSN investors received the highest price and whether the directors of Hansen Medical Inc acted in the best interest of Hansen Medical Inc company and its shareholders.
If you purchased Hansen Medical Inc (NASDAQ: HNSN) prior to April 20, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.
Thieler Law Corp
2534 State Street - Suite 406,
San Diego, CA 92101
by
email: mail@thielerlaw.com
or
telephone at +1 (619) 377 - 4324
or
visit our website http://www.thielerlaw.com/
or
Facsimile: +1 (619) 785 – 3185